Edition:
United States

People: Genomic Health Inc (GHDX.OQ)

GHDX.OQ on NASDAQ Stock Exchange Global Select Market

61.93USD
18 Apr 2019
Change (% chg)

$0.54 (+0.88%)
Prev Close
$61.39
Open
$61.53
Day's High
$62.57
Day's Low
$60.79
Volume
174,629
Avg. Vol
153,513
52-wk High
$91.03
52-wk Low
$31.13

Febbo, Phillip 

Dr. Phillip Febbo, M.D., serves as Chief Medical Officer of the Company, since August 2013. Dr. Febbo served as Director of Applied Genomics at the University of California, San Francisco. While at UCSF, Dr. Febbo was the Co-Leader of the Prostate Cancer Program at the UCSF Helen Diller Family Comprehensive Cancer Center and the Program Principal Investigator of the Translational Research Program for the Alliance for Clinical Trials in Oncology. From September 2004 to June 2010, Dr. Febbo served as Associate Professor of Medicine and Molecular Genetics and Microbiology at Duke University Medical Center’s Institute of Genome Sciences and Policy. Dr. Febbo holds a B.A. in Biology from Dartmouth College and an M.D. from the University of California, San Francisco, and completed his internal medicine residency at the Brigham and Women’s Hospital.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kimberly Popovits

4,117,300

Gordon Cole

1,606,770

Steven Shak

1,418,200

Phillip Febbo

--

Laura Kammeyer

--

Frederic Pla

1,588,330
As Of  30 Dec 2017